• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Study: PharmaJet’s needle-free injection tech linked to higher workplace flu shot compliance

June 14, 2017 By Sarah Faulkner

PharmaJetPharmaJet touted its needle-free injection technology in a study that evaluated the use of its device in company-hosted flu clinics.

The report, which was published in ONdrugDelivery, described the experience that patients and healthcare providers had with its Stratis needle-free injection system in influenza clinics hosted by companies including BP Oil, Cargill, Xerox and the Denver International Airport.

PharmaJet’s device is designed to administer medication intramuscularly or subcutaneously, without the use of needles. The company describes the technology as a way to prevent cross-contamination between needles and enhance patient compliance.

Only 20% of healthy, working adults ages 18 – 49 receive an annual flu shot, despite the benefits of vaccination, according to PharmaJet.

The Golden, Colo.-based company reported that over 90% of patients and healthcare providers were satisfied with the needle-free shot and that 33% of healthcare providers thought that having a needle-free option would increase vaccination rates in their workplace programs.

PharmaJet also found that 95% of patients would choose to receive their flu shot with a needle-free injection during next year’s flu vaccination season.

“Our experience last flu season is consistent with previous patient and provider surveys. Offering our needle-free technology as an option in workplace flu clinics can be beneficial to employee health while improving organization productivity,” chairman & CEO Ron Lowy said in prepared remarks. “We look forward to expanding the availability of needle-free in workplace immunization clinics this fall.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: PharmaJet

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS